Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-26 @ 4:09 AM
Study NCT ID:
NCT05594927
Status:
RECRUITING
Last Update Posted:
2024-08-07
First Post:
2022-10-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)
Sponsor:
Beijing Shenogen Biomedical Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-17
First Submit QC Date:
None
Study First Post Date:
2022-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-05
Last Update Post Date:
2024-08-07
Last Update Post Date Type:
ACTUAL